MD HB1377

Establishes the Redirecting Safe Prescription Drugs Pilot Program to expand medication access for underserved populations, reduce pharmaceutical waste, and prevent drug diversion

Requires the Secretary of Health to collaborate with the federal Drug Enforcement Agency (DEA) and four Maryland repositories registered to participate in National Prescription Drug Take Back Days

Participating repositories must separate and redirect eligible, noncontrolled, unopened prescription medications to the State's existing Prescription Drug Repository Program, while ensuring controlled substances go to the DEA

Secretary of Health must report to the State Board of Pharmacy and General Assembly by October 1, 2027 on the number and types of medications collected and packaging compliance

Takes effect July 1, 2026 and automatically expires on December 31, 2027 (18-month pilot period)